The letter was described by people who had read ... It punctured the air of inevitability about the future of psychedelic medicine and led to a management shake-up and mass layoffs at Lykos ...
Polyrizon Ltd. has announced a non-binding Letter of Intent with a biotech company focused on psychedelic-derived therapeutics to develop a new intranasal formulation for treatment applications ...
announced today that it has signed a non-binding Letter of Intent (LOI) with a biotech company focused on psychedelic-derived therapeutics (“the psychedelic company”), to develop a novel intranasal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback